Ellen Cooper | Profiles RNS

Ellen Rae Cooper, MD

Professor

Boston University Chobanian & Avedisian School of Medicine

Pediatrics

Infectious Diseases

MD, University of Cincinnati College of Medicine
MA, Johns Hopkins University
BS, Wellesley College

Websites

	Boston Medical Center Provider Profile
	ResearchGate

ORCID : 0000-0001-8280-5192

Dr. Ellen Cooper is Professor of Pediatrics at Chobanian and Avedisian School of Medicine, and is in the Division of Pediatric Infectious Diseases at Boston Medical Center. She founded and still directs the Pediatric HIV Program which now also includes an Adolescent HIV Initiative. In addition she leads the Transition Program for older adolescents who are transitioning to adult care.

She has published widely on the subject of Pediatric HIV treatment and care. She was a principal investigator of a large US based study designed to answer questions surrounding the perinatal transmission of HIV, and this continues to be one of her special interests. She was one of the original members of the HIV Consensus Committee, whose purpose was to establish guidelines for the diagnosis and treatment of HIV infected infants in the US, and her expertise led her to focus also on treatment and care in a number of high burden and low resource countries. She has worked in sites in Uganda, Cameroon, South Africa, Zambia, and in Ethiopia.

She was a participant, trainer and advisor to curriculum development and implementation for the MTCT-Plus Programs in Africa, and served as a technical advisor for ICAP, Columbia in their efforts to establish a Center of Excellence for the care of HIV infected children in Zambia. She continues to be an active participant in the NIH sponsored IMPAACT Network.

A Phase 2/3, open-label, multicenter, multi-cohort, 2-part study evaluating pharmacokinetics (PK), safety, and efficacy of once-daily cobicistat-boosted darunavir (DRV/co) administered with a backgrou
02/10/2014 - 02/03/2016 (PI)
Gilead Sciences, Inc.

A Phase 2/3 Multicenter, Open-label, Multicohort, Two-Part Study Evaluating the Pharmacokinetics (PK), Safety, and Antiviral Activity of Elvitegravir (EVG) Administered with a Background Regimen (BR)
02/04/2014 - 01/31/2016 (PI)
Gilead Sciences, Inc.

A phase 2/3 open-label study of pharmacokinetics, safety and antiviral activity of the elvitegravir/cobicistat/emtricitabine/tenofovir disoproxii fumarte single table regimen (STR) in HIV-1 infected a
10/01/2012 - 09/30/2014 (PI)
Gilead Sciences, Inc.

An open label prospective, pharmacokinetic/pharmacodynamic and safety evaluation of intravenous oseltamivir, Tamiflu, in the treatment of children 1 to 12 years of age with confirmed influenza
04/30/2010 - 09/30/2013 (PI)
Roche Pharmaceuticals

An open label prospective, pharmacokinetic/pharmacodynamic and safety evaluation of intravenous oseltamivir (Tamiflu) in the treatment of infants less than one year of age with influenza infecti
08/01/2010 - 08/15/2013 (PI)
F. Hoffmann-La Roche, Ltd.

A Pivotal Phase 3 Study of MEDI-524 (Numax), an Enhanced Potency Humanized Respiratory Syncytial Virus (RSV) Monoclonal Antibody, for the Prophylaxis of Serious RSV Disease in High-Risk Children
09/14/2004 - 12/31/2009 (PI)
MedImmune, Inc.

A Prospective, Non-Interventional Study to Evaluate the Incidence of Hospitalizations and Medically-Attended Lower Respiratory Tract Infection (MALRI) in Premature Infants 32 to 35 Weeks Gestational Age Who are Not Recommended to Receive Prophylaxis for R
12/22/2006 - 06/30/2007 (PI)
MedImmune, Inc.

RSV Outbreaks in the Boston Medical Center NICU: The Role of Palibizumab in Prevention
10/01/2002 - 09/30/2003 (PI)
MedImmune, Inc.

Ryan White HIV/AIDS Program Part D Continuation Funding for Services to Women, Infants, Children and Youth (WICY) in the Boston Eligible Metropolitan Area (EMA)
08/01/2022 - 07/31/2024 (PI)
HIV/AIDS Bureau/HRSA/DHHS

A multi- site observational study to assess safety and effectiveness of prenatal exposure to…
05/18/2020 - 12/31/2023 (PI)
ViiV Healthcare

An Epidemiologic Study of Pregnant Women and Their Newborn Infants to Describe Immune Status…
10/12/2015 - 03/15/2021 (PI)
Pfizer, Inc Pfizer, Inc

PlusCare: Mobile platform to increase linkage to care in adolescents living with HIV/AIDS
05/01/2018 - 09/30/2020 (PI)
Dimagi Inc. National Institute o
5R44MH117956-03

The SENTINEL 1 Study
12/02/2014 - 04/30/2017 (PI)
Astrazeneca Pharmaceuticals

Conducting CASG 117 - A Pharmacokinetic / Pharmcodynamic and Safety Evaluation of Investigational In
03/01/2010 - 09/30/2013 (PI)
Social & Scientific Systems Inc. NIH-NIAID

Combination Antiviral Focus Group
11/01/2009 - 09/30/2013 (PI)
Social & Scientific Systems Inc. NIH-NIAID

AIDSTAR - One Program
08/01/2010 - 12/31/2012 (PI)
John Snow, Inc. USAID

Title IV Case findings Early Intervention
10/01/2001 - 08/31/2012 (PI)
Justice Resource Institute DHHS

MassCARE (Community AIDS Resource Enhancement)
10/01/2001 - 06/30/2011 (PI)
DPH HRSA

Showing 10 of 22 results. Show All Results

Title

Yr	Title	Project-Sub Proj	Pubs
2007	PHASE I/II STUDY OF PROTEASE INHIBITOR BMS 232632 IN HIV INF INFANTS, CHILDREN	2M01RR000533-39-8124	503
2006	STUDY OF PROTEASE INHIBITOR BMS 232632 IN HIV INF INFANTS, CHILDREN	5M01RR000533-38-5563	503
2005	MORPHOLOGIC AND METABOLIC ABNORMALITIES IN HIV INFECTED AND UNIFECTED WOMEN	5M01RR000533-37-5421	503
2005	A NOVEL METHOD TO DETERMINE HIV INCIDENCE AMONG YOUTH (ATN 022, VERSION 10)	5M01RR000533-37-5432	503
2005	PROTEASE INHIBITOR BMS 232632 IN HIV INF INFANTS, CHILDREN	5M01RR000533-37-5390	503

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Sabharwal V, Bartolome R, Hassan SA, Levesque BM, Camelo IY, Wachman EM, Figueira M, Yarrington CD, Cooper ER, Barnett ED, Parker MG. Mother-Infant Dyads with COVID-19 at an Urban, Safety-Net Hospital: Clinical Manifestations and Birth Outcomes. Am J Perinatol. 2021 06; 38(7):741-746.View Related Profiles.

Levesque, Bernadette
Yarrington, Christina
Wachman, Elisha
Barnett, Elizabeth
Cooper, Ellen
Parker, Margaret
Figueira, Marisol
Bartolome, Ruby
Sabharwal, Vishakha

PMID: 33853145

Epstein RL, Penwill N, Clarke DF, Hamilton S, Horbowicz K, Dorfman D, Moses JM, Cooper ER. "Meds-in-Hand" Intervention to Reduce Critical Process Delays in Pediatric Human Immunodeficiency Virus Post-Exposure Prophylaxis. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):196-200.View Related Profiles.

Clarke, Diana
Cooper, Ellen
Moses, James
Horbowicz, Kevin
Epstein, Rachel

PMID: 32347312; PMCID: PMC7996639; DOI: 10.1093/jpids/piaa033;

Hale JE, Platt CD, Bonilla FA, Hay BN, Sullivan JL, Johnston AM, Pasternack MS, Hesterberg PE, Meissner HC, Cooper ER, Barmettler S, Farmer JR, Fisher D, Walter JE, Yang NJ, Sahai I, Eaton RB, DeMaria A, Notarangelo LD, Pai SY, Comeau AM. Ten Years of Newborn Screening for Severe Combined Immunodeficiency (SCID) in Massachusetts. J Allergy Clin Immunol Pract. 2021 05; 9(5):2060-2067.e2. PMID: 33607339; PMCID: PMC8113135; DOI: 10.1016/j.jaip.2021.02.006;

McEntire CRS, Fong KT, Jia DT, Cooper ER, Cervantes-Arslanian AM, Mateen FJ, Anand P, Thakur KT. Central nervous system disease with JC virus infection in adults with congenital HIV. AIDS. 2021 02 02; 35(2):235-244.View Related Profiles.

Cervantes-Arslanian, Anna
Cooper, Ellen
Anand, Pria

PMID: 33394671; PMCID: PMC7945987; DOI: 10.1097/QAD.0000000000002734;

Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, Bhadelia N, Fagan MA, Linas BP, Assoumou SA, Ieong MH, Lin NH, Cooper ER, Brade KD, White LF, Barlam TF, Sagar M. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis. 2020 Oct; 99:28-33.View Related Profiles.

McLaughlin, Angela
Linas, Benjamin
Bielick, Catherine
Hamer, Davidson
Cooper, Ellen
White, Laura
Wetzler, Lee
Sagar, Manish
Fagan, Maura
Ieong, Michael
Bhadelia, Nahid
Lin, Nina
Sinha, Pranay
Assoumou, Sabrina
Barlam, Tamar

PMID: 32721528; PMCID: PMC7591937; DOI: 10.1016/j.ijid.2020.07.023;

Haffey M, Bellamy P, McLaud D, O’Brien A, Moloney C, Clarke D, Amo K, Spinale S, Cooper E, Pelton S. Achieving US Public Health metrics in care of youth with HIV. Presented at the HRSA Ryan White and Global HIV/AIDS Program National Meeting, Boston, MA. 2018.
Epstein R, Penwill N, Clarke D, Hamilton S, Moses J, Cooper E. Reducing Delays to Antiretroviral Receipt in Children Prescribed Post Exposure Prophylaxis for HIV. Presented at ID Week, San Diego CA. 2017.

Clarke DF, Yildirim I, Cooper ER. Rapid Initiation of Antiretrovirals in Two Newly Diagnosed HIV-infected Infants. Pediatr Infect Dis J. 2017 Jan; 36(1):61-62.View Related Profiles.

Clarke, Diana
Cooper, Ellen
Yildirim, Inci

PMID: 27749654

Epstein R, Penwill N, Clarke D, Hamilton S, Horbowicz K, Dorfman D, Moses J, Cooper E. Reducing Delays to Receipt of PEP in the Pediatric Emergency Department: Meds in Hand and a Multidisciplinary Team Approach. Presented at the Quality Improvement and Safety Conference organized at Boston Medical Center and Boston University School of Medicine (winner of patient safety award) Boston, MA. 2017.

Peluso AM, Harnish BA, Miller NS, Cooper ER, Fujii AM. Effect of young sibling visitation on respiratory syncytial virus activity in a NICU. J Perinatol. 2015 Aug; 35(8):627-30.View Related Profiles.

Fujii, Alan
Cooper, Ellen
Miller, Nancy

PMID: 25836315; DOI: 10.1038/jp.2015.27;

Showing 10 of 143 results. Show More

Clarke DF, Moloney C, Cooper ER. Iatrogenic Cushing's Syndrome due to pharmacokinetic interaction of intra-ocular corticosteroids and lopinavir/ritonavir in an HIV- infected adolescent: A case report. J AIDS Clin. Res. 2014.

Ojikutu B, Higgins-Biddle M, Greeson D, Phelps BR, Amzel A, Okechukwu E, Kolapo U, Cabral H, Cooper E, Hirschhorn LR. The association between quality of HIV care, loss to follow-up and mortality in pediatric and adolescent patients receiving antiretroviral therapy in Nigeria. PLoS One. 2014; 9(7):e100039.View Related Profiles.

Cooper, Ellen
Cabral, Howard

PMID: 25075742; PMCID: PMC4116117; DOI: 10.1371/journal.pone.0100039;

Chakraborty,R, Van Dyke, Flynn P, Aldrovandi G, ChadwickE, Cooper ER, et al. Committee on Pediatric AIDS, American Academy of Pediatrics Policy Statement Transitioning HIV-Infected Youth into Adult Health Care. Pediatrics. 2013; 132:192-197.
Dobbs KD, Moloney C, Toomey K, Cooper E. Seroconversion rates in HIV infected children and adolescents receiving double dose Hepatitis B vaccine after initial poor response to standard regimen. XIX International HIV Conference, Washington, DC. 2012.
Greeson D, Ojikitu B, Bolton C, Phelps B, Bubela P, Cabral H, Cooper, E. Challenges to 2010 Pediatric Guideline Implementation in Zambia. XIX International HIV Conference; Washington, DC. 2012.
Ojikutu D, Greeson D, Phelps B, Azeez A, Cabral H, Cooper E. Patient and Site Level Predictors of Loss to Follow up and Mortality in Pediatric and Adolescent Patients in The Nigerian National Program. XIX International HIV Conference, Washington, DC. 2012.

Lipshultz SE, Shearer WT, Thompson B, Rich KC, Cheng I, Orav EJ, Kumar S, Pignatelli RH, Bezold LI, LaRussa P, Starc TJ, Glickstein JS, O'Brien S, Cooper ER, Wilkinson JD, Miller TL, Colan SD. Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). J Am Coll Cardiol. 2011 Jan 4; 57(1):76-85. PMID: 21185505; PMCID: PMC3243620; DOI: 10.1016/j.jacc.2010.08.620;

Comeau A, Hale J, Cooper E, et al. Establishing Follow-up Protocols for Low Frequency Events in SCID Newborn Screening: Working with Specialists New to NBS. National Newborn Screening Meeting. San Diego, CA. 2011.
O’Brien S, Sasaki N, Eidem B, Colan S, Shearer W, Cheng I, Thompson B, Wilkinson J, Cooper E, et al. Left Ventricular Diastolic Dysfunction in HIV-Negative Infants Exposed In Utero to Antiretroviral Therapy from HIV-Positive Mothers: Prospective NHLBI CHAART-1 Study. Presented at the American Heart Association Scientific Meetings. 2011.

Levin MJ, Moscicki AB, Song LY, Fenton T, Meyer WA, Read JS, Handelsman EL, Nowak B, Sattler CA, Saah A, Radley DR, Esser MT, Weinberg A. Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old. J Acquir Immune Defic Syndr. 2010 Oct; 55(2):197-204. PMID: 20574412; PMCID: PMC3033215; DOI: 10.1097/QAI.0b013e3181de8d26;

Comeau AM, Hale JE, Pai SY, Bonilla FA, Notarangelo LD, Pasternack MS, Meissner HC, Cooper ER, DeMaria A, Sahai I, Eaton RB. Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency. J Inherit Metab Dis. 2010 Oct; 33(Suppl 2):S273-81. PMID: 20490925; DOI: 10.1007/s10545-010-9103-9;

Henry-Reid LM, O'Connor KG, Klein JD, Cooper E, Flynn P, Futterman DC. Current pediatrician practices in identifying high-risk behaviors of adolescents. Pediatrics. 2010 Apr; 125(4):e741-7. PMID: 20308220

Brogly SB, Foca M, Deville JG, Mirochnick M, Scott GB, Mofenson LM, Read JS, Viani RM, Burchett SK, Cooper ER, Browning R, Shapiro DE. Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants. J Acquir Immune Defic Syndr. 2010 Jan; 53(1):154-7.View Related Profiles.

Cooper, Ellen
Mirochnick, Mark
Brogly, Susan

PMID: 20035168; PMCID: PMC3241607; DOI: 10.1097/QAI.0b013e3181b3adc2;

Lipshultz S, Torres S, Wilkinson JD, Shearer WT, Thompson B, Rich K, Cheng I, Orav EJ, Kumar S, Pignatelli RH, Bezold LI, La Russa P, Starc TJ, Glickstein JS, O’Brien S, Cooper, ER, et al. Mitochondrial DNA Mutations in HIV Seropositive Children Receiving Combination Antiretroviral Therapy. Presented at American Heart Association Scientific Sessions. Chicago, IL. 2010.

Carbonell-Estrany X, Simões EA, Dagan R, Hall CB, Harris B, Hultquist M, Connor EM, Losonsky GA. Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial. Pediatrics. 2010 Jan; 125(1):e35-51. PMID: 20008423; DOI: 10.1542/peds.2008-1036;

Weinberg A, Huang S, Fenton T, Patterson-Bartlett J, Gona P, Read JS, Dankner WM, Nachman S. Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment. J Acquir Immune Defic Syndr. 2009 Sep 1; 52(1):17-24. PMID: 19617848; PMCID: PMC2836885; DOI: 10.1097/QAI.0b013e3181b011f6;

Kankasa C, Carter RJ, Briggs N, Bulterys M, Chama E, Cooper ER, Costa C, Spielman E, Katepa-Bwalya M, M'soka T, Ou CY, Abrams EJ. Routine offering of HIV testing to hospitalized pediatric patients at university teaching hospital, Lusaka, Zambia: acceptability and feasibility. J Acquir Immune Defic Syndr. 2009 Jun 1; 51(2):202-8. PMID: 19504732; PMCID: PMC5117627

Lipshultz SE, Shearer WT, Thompson B, Rich K, Cheng I, Orav EJ, Kumar S, Pignatelli RH, Bezold LI, LaRusa P, Starc JJ, Glickstein J, O’Brien SO, Cooper ER, Wilkinson JD, Miller TL, Colan SD. Antiviral Therapy Cardiac Effects in HIV-Infected Children: the Multi-Center NHLBI Cardiac Highly Active Antiretroviral Therapy (CHAART II) Study. Presented at the Meeting of the American Heart Association. Orlando, FL. 2009.
Brogly SB, Foca M, Deville JG, Mirochnick M, Mofenson LM, Read JS, Viani RM, Burchett SK, Browning R, Cooper ER. Potential Confounding of the Association Between Exposure to Nucleoside Analogues and mitochondrial dysfunction in HIV-Uninfected and Indeterminate Infants. Accepted for presentation at the 27th Conference of Retroviruses and Opportunistic Infections, Toronto, Canada. 2009.
O’Brien S, Eidem B, Colan SD, Shearer WT, Cheng I, Rich K, Thompson B, Wilkinson JD, Miller TL, Orav EJ, Pignatelli RH, Bezold LI, Kumar S, LaRussa P, Starc TJ, Glickstein J, McIntosh K, Cooper ER, Lipshultz SE. Antiretroviral Therapy and HIV-Associated Left Ventricular Diastolic Dysfunction in Uninfected but ART Exposed Infants Born to HIV-Infected Women: The Prospective NHLBI CHAART-1 Study. Presented at the American College of Cardiology Meeting, Orlando, FL. 2009.
Lipshultz SE, Shearer WT, Rich K, Thompson B, Cheng I, Miller A, Orav EJ, Kumar S, Pignatelli RH, Bezold LI, LaRussa P, Starc TJ, Glickstein J, O’Brien S, McIntosh K, Cooper ER, Colan SD. Antiretroviral Therapy Associated Cardiotoxicity in Uninfected but ART-Exposed Infants Born to HIV-Infected Women: The Prospective NHLBI CHAART-1 Study. Presented at the American Heart Association Meetings, New Orleans, LA. 2008.
Cooper ER. Pocket Pediatrics (Reines, ed.). Varicella Zoster Virus, Respiratory Syncytial Virus, Rocky Mountain Spotted Fever. Rocket Medicine. New York. 2008.
Tandon R, Dwan J, Cooper ER, Grana J, Handy H, Sullivan M. A Model Clinic for Care of HIV Infected Pregnant Women. Presented at Infectious Diseases Society of America, Washington, DC. 2008.
Crosby SS, Piwowarczyk LA, Cooper ER. Immigrant Medicine (Walker, Barnett, eds.). HIV Infection in Immigrants. Elsievier Publications. Philadelphia. 2007.

Chantry CJ, Frederick MM, Meyer WA, Handelsman E, Rich K, Paul ME, Diaz C, Cooper ER, Foca M, Adeniyi-Jones SK, Moye J. Endocrine abnormalities and impaired growth in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2007 Jan; 26(1):53-60. PMID: 17195707

Frenkel LM, McKernan J, Dinh PV, Goldman D, Hitti J, Watts DH, Cooper ER, Dragavon J, Coombs RW. HIV type 1 zidovudine (ZDV) resistance in blood and uterine cervical secretions of pregnant women. AIDS Res Hum Retroviruses. 2006 Sep; 22(9):870-3. PMID: 16989612

Lipshultz SE, Shearer WT, Thompson B, Rich K, Cheng I, Milton A, Orav EJ, Pignatelli RH, Bezold LI, LaRussa P, Starc TJ, Glickstein J, McIntosh K, Cooper ER, O’Brien S, Colan SD. Antiretroviral therapy-associated cardiotoxicity. Society of Pediatric Research, San Francisco, California. 2006.
Kankasa C, Katepa-Bwalya M, Spielman E, Abrams E, Bulterys M, Cooper E. Presented at the Presidential Emergency Plan for AIDS Relief (PEPFAR) International Conference. Durban, South Africa. Center of Excellence for Care and Treatment of Pediatric HIV/AIDS in Zambia: Current Activities. 2006.
Kankasa C, Katepa-Bwalya M, Katuta R, Spielman E, Briggs N, Cooper E, Abrams EJ, Bulterys M. Universal counseling and testing in hospitalized children in the Department of Paediatrics & Child Health, University Teaching Hospital, Lusaka, Zambia. Presented at the Presidential Emergency AIDS Relief (PEPFAR) International Conference. Durban, South Africa. 2006.
Cooper ER. The Columbia Clinical Manual: Care and Treatment of HIV/AIDS in Resource Limited Settings. Nutritional assessment and support for children with HIV. Trustees of Columbia University. New York. 2005; 74-89.
Lipshultz SE, Shearer WT, Rich K, Thompson B, Cheng I, Harmon T, Orav EJ, Pignatelli RH, Bezold LI, LaRussa P, Starc TJ, Glickstein J, O’Brien S, McIntosh K, Cooper ER, Colan SD. Antiretroviral therapy-associated cardiotoxicity in uninfected but ART-exposed infants born to HIV infected women: the prospective NHLB, CHAART-1 Study. Heart Association Meetings. Dallas, TX. 2005.

Paul ME, Chantry CJ, Read JS, Frederick MM, Lu M, Pitt J, Turpin DB, Cooper ER, Handelsman EL. Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women: the women and infants transmission study. Pediatr Infect Dis J. 2005 Jan; 24(1):46-56. PMID: 15665710

Cooper ER, Harnisch BA, Fujii AM, et al. Society for Pediatric Research, San Francisco, CA. RSV in the NICU: Risks factors, spectrum of disease, and the role of routine surveillance in prevention of nosocomial infections. 2004.
Cooper ER, DiMauro S, Sullivan M, et al. Biopsy confirmed mitochondrial dysfunction in an HIV exposed infant whose mother received combination antiretrovirals during the last 6 weeks of pregnancy. XV International AIDS Conference, Bangkok, Thailand. 2004.
Cooper ER. Nutritional assessment and support for children with HIV: A global perspective. The Columbia Clinical Manual. 2004.
Cooper ER. Medical Management of AIDS in children (Shearer, Hanson, eds.). Infection control in hospital, school, and community: distinguishing real risk from perceived danger. WB Saunders CO. Philadelphia. 2003.

Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, Hayani K, Handelsman E, Smeriglio V, Hoff R, Blattner W. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002 Apr 15; 29(5):484-94. PMID: 11981365

Meyers A, Shah A, Cleveland RH, Cranley WR, Wood B, Sunkle S, Husak S, Cooper ER. Thymic size on chest radiograph and rapid disease progression in human immunodeficiency virus 1-infected children. Pediatr Infect Dis J. 2001 Dec; 20(12):1112-8.View Related Profiles.

Meyers, Alan
Cooper, Ellen
Cranley, William

PMID: 11740315

Mirochnick M, Cooper E, Capparelli E, McIntosh K, Lindsey J, Xu J, Jacobus D, Mofenson L, Bonagura VR, Nachman S, Yogev R, Sullivan JL, Spector SA. Population pharmacokinetics of dapsone in children with human immunodeficiency virus infection. Clin Pharmacol Ther. 2001 Jul; 70(1):24-32.View Related Profiles.

Cooper, Ellen
Mirochnick, Mark

PMID: 11452241

Babl FE, Cooper ER, Kastner B, Kharasch S. Prophylaxis against possible human immunodeficiency virus exposure after nonoccupational needlestick injuries or sexual assaults in children and adolescents. Arch Pediatr Adolesc Med. 2001 Jun; 155(6):680-2. PMID: 11386957

Langston C, Cooper ER, Goldfarb J, Easley KA, Husak S, Sunkle S, Starc TJ, Colin AA. Human immunodeficiency virus-related mortality in infants and children: data from the pediatric pulmonary and cardiovascular complications of vertically transmitted HIV (P(2)C(2)) Study. Pediatrics. 2001 Feb; 107(2):328-38. PMID: 11158466

Cooper ER, Christiansen D, Lloyd RM et. al. Comparison of HIV-1 proviral DNA and plasma RNA genotyping, and its utility in the selection of antiretroviral therapy in children. Conference on Retrovirology, Chicago, IL. 2001.
Paul M, Frederick M, Chantry C, Turpin D, Pitt J, Handelsman E, Cooper E, Read J. Morbidity in uninfected infants born to HIV-infected women as measured by CDC clinical classification. Society for Pediatric Research, Baltimore, MD. 2001.

Cooper ER, Charurat M, Burns DN, Blattner W, Hoff R. Trends in antiretroviral therapy and mother-infant transmission of HIV. The Women and Infants Transmission Study Group. J Acquir Immune Defic Syndr. 2000 May 1; 24(1):45-7. PMID: 10877494

Babl FE, Cooper ER, Damon B, Louie T, Kharasch S, Harris JA. HIV postexposure prophylaxis for children and adolescents. Am J Emerg Med. 2000 May; 18(3):282-7. PMID: 10830685

Babl FE, Ram S, Barnett ED, Rhein L, Carr E, Cooper ER. Neonatal gonococcal arthritis after negative prenatal screening and despite conjunctival prophylaxis. Pediatr Infect Dis J. 2000 Apr; 19(4):346-9.View Related Profiles.

Barnett, Elizabeth
Cooper, Ellen

PMID: 10783027

Pitt J, Henrard D, FitGerald G, Mofenson L, Lew J, Hillyer G, Mendez H, Cooper E, Hanson C, and Rich K for the Women and Infants Transmission Study (WITS). Human immunodeficiency virus (HIV) type 1 antibodies in perinatal HIV-1 infection: association with human HIV-1 transmission, infection, and disease progression. J Infect Dis. 2000; 182:1243-1246.
Mirochnick M, Cooper ER, Xu J et al. Pharmacokinetics of dapsone in HIV-infected children. Conference on Retrovirology, San Francisco, CA. 2000.
Meyers A, Shah F, Cleveland R, Crauley W, Wood, B, Sunkle S, Husak S, Cooper E. Thymic involution of plain chest radiograph and rapidly progressive disease in HIV-1. Society for Pediatric Research, Boston, MA. 2000.

Rich KC, Fowler MG, Mofenson LM, Abboud R, Pitt J, Diaz C, Hanson IC, Cooper E, Mendez H. Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group. Pediatrics. 2000 Jan; 105(1):e8. PMID: 10617745

Shearer WT, Lipshultz SE, Easley KA, McIntosh K, Pitt J, Quinn TC, Kattan M, Goldfarb J, Cooper E, Bryson Y, Kovacs A, Bricker JT, Peavy H, Mellins RB, Heart N, Institute LB. Alterations in cardiac and pulmonary function in pediatric rapid human immunodeficiency virus type 1 disease progressors. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Study Group. Pediatrics. 2000 Jan; 105(1):e9. PMID: 10617746; PMCID: PMC4331103

Mirochnick M, Cooper E, McIntosh K, Xu J, Lindsey J, Jacobus D, Mofenson L, Sullivan JL, Dankner W, Frenkel LM, Nachman S, Wara DW, Johnson D, Bonagura VR, Rathore MH, Cunningham CK, McNamara J. Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected children. Antimicrob Agents Chemother. 1999 Nov; 43(11):2586-91.View Related Profiles.

Cooper, Ellen
Mirochnick, Mark

PMID: 10543733; PMCID: PMC89529

Burns DN, FitzGerald G, Semba R, Hershow R, Zorrilla C, Pitt J, Hammill H, Cooper ER, Fowler MG, Landesman S. Vitamin A deficiency and other nutritional indices during pregnancy in human immunodeficiency virus infection: prevalence, clinical correlates, and outcome. Women and Infants Transmission Study Group. Clin Infect Dis. 1999 Aug; 29(2):328-34. PMID: 10476737

Kovacs A, Schluchter M, Easley K, Demmler G, Shearer W, La Russa P, Pitt J, Cooper E, Goldfarb J, Hodes D, Kattan M, McIntosh K. Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med. 1999 Jul 08; 341(2):77-84. PMID: 10395631; PMCID: PMC4280563

Starc TJ, Langston C, Goldfarb J, Colin AA, Cooper ER, Easley KA, Sunkle S, Schluchter MD. Unexpected non-HIV causes of death in children born to HIV-infected mothers. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. Pediatrics. 1999 Jul; 104(1):e6. PMID: 10390292

McIntosh K, Cooper E, Xu J, Mirochnick M, Lindsey J, Jacobus D, Mofenson L, Yogev R, Spector SA, Sullivan JL, Sacks H, Kovacs A, Nachman S, Sleasman J, Bonagura V, McNamara J. Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials Group. Pediatr Infect Dis J. 1999 May; 18(5):432-9.View Related Profiles.

Cooper, Ellen
Mirochnick, Mark

PMID: 10353516

Hanson IC, Antonelli TA, Sperling RS, Oleske JM, Cooper E, Culnane M, Fowler MG, Kalish LA, Lee SS, McSherry G, Mofenson L, Shapiro DE. Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15; 20(5):463-7. PMID: 10225228

Blattner W, Charurat M, Cooper ER, Burns D et al. Trends in HIV transmission in the WITS cohort: Impact of 076 and HAART therapy. Conference on Global Strategies to Reduce HIV Infection, Montreal, Canada. 1999.
Babl FE, Kastner B, Kharasch S, Cooper ER. The use of HIV post-exposure prophylaxis (PEP) in children and adolescents in the United States and Canada. The American Pediatric Society and the Society for Pediatric Research, San Francisco, CA. 1999.
Colin AA, Cooper ER, Goldfarb J et al. Pulmonary related deaths in the P2C2 HIV study. European Respiratory Society, Madrid, Spain. 1999.
Mirochnick M, Cooper E, Xu J et al. Population pharmacokinetics of Dapsone in HIV-infected children. The Society for Pediatric Research, San Francisco, CA. 1999.

Pitt J, Schluchter M, Jenson H, Kovacs A, LaRussa P, McIntosh K, Boyer P, Cooper E, Goldfarb J, Hammill H, Hodes D, Peavy H, Sperling R, Tuomala R, Shearer W. Maternal and perinatal factors related to maternal-infant transmission of HIV-1 in the P2C2 HIV study: the role of EBV shedding. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV-1 Infection (P2C2 HIV) Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15; 19(5):462-70. PMID: 9859959

Diaz C, Hanson C, Cooper ER, Read JS, Watson J, Mendez HA, Pitt J, Rich K, Smeriglio V, Lew JF. Disease progression in a cohort of infants with vertically acquired HIV infection observed from birth: the Women and Infants Transmission Study (WITS). J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jul 1; 18(3):221-8. PMID: 9665498

Cooper ER, Hanson C, Diaz C, Mendez H, Abboud R, Nugent R, Pitt J, Rich K, Rodriguez EM, Smeriglio V. Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection. Women and Infants Transmission Study Group. J Pediatr. 1998 May; 132(5):808-12. PMID: 9602190

Pitt J, Goldfarb J, Schluchter M, Kovacs A, Cooper E, Hodes D, McIntosh K, Peavy H, Shearer W. HIV vertical transmission rate determinations are subject to differing definitions and therefore different rates. The Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. J Clin Epidemiol. 1998 Feb; 51(2):159-64. PMID: 9474076

USDHHS, NIH, AAP Task Force. Antiretroviral therapy and medical management of pediatric HIV infection. Pediatrics. 1998; 102(4):1000-1063.
IMpact - RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998; 102:531-537.
McIntosh K, Cooper E, Mirochnick M et al. The toxicity and efficacy of daily vs. weekly dapsone in HIV-infected children. Presented at the Society for Pediatric Research, New Orleans, LA. 1998.

Rich KC, Brambilla D, Pitt J, Moye J, Cooper E, Hillyer G, Mendez H, Fowler MG, Landay A. Lymphocyte phenotyping in infants: maturation of lymphocyte subpopulations and the effects of HIV infection. Clin Immunol Immunopathol. 1997 Dec; 85(3):273-81. PMID: 9400627

Rich KC, Chang BH, Mofenson L, Fowler MG, Cooper E, Pitt J, Hillyer GV, Mendez H. Elevated CD8+DR+ lymphocytes in HIV-exposed infants with early positive HIV cultures: a possible early marker of intrauterine transmission. Women and Infants Transmission Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jul 01; 15(3):204-10. PMID: 9257655

Pitt J, Henrard D, Fitzgerald G, Lew J, Mendez H, Cooper ER, et al. Association of HIV antibodies and ICD p24 antigen with peri-natal HIV-1 transmission. Presented at the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, DC. 1997.
Cooper ER, Damon B, Reinke D et al. Clinical outcome and change in HIV-1 viral load following successful treatment of Mycobacterium avium complex infection in children with HIV disease. Presented at the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, DC. 1997.

Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group. Pediatrics. 1997 Jan; 99(1):93-9. PMID: 8989345

Frenkel L, Arcuna L, Edelstein R, Melvin A, Coombs R, Watts D, Berry S, Sampoleo R, Cooper ER. HIV-1 genotypic resistance and RNA levels in the blood and cervical secretions of pregnant women. Presented at the Meeting of the Infectious Disease Society of America, San Francisco, CA. 1997.
Starc T, Goldfarb J, Colin A, Cooper ER, et al. High incidence of traumatic deaths in infants born to HIV infected women. Ambulatory Pediatric Association, Washington, DC. 1997.
Langston C, Colin A, Cooper ER, et al. Mortality in pediatric HIV: causes and contributing factors in the P2C2 study. Society for Pediatric Research, Washington, DC. 1997.

Cooper ER, Nugent RP, Diaz C, Pitt J, Hanson C, Kalish LA, Mendez H, Zorrilla C, Hershow R, Moye J, Smeriglio V, Fowler MG. After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Transmission Study Group. J Infect Dis. 1996 Dec; 174(6):1207-11. PMID: 8940210

Bremer JW, Lew JF, Cooper E, Hillyer GV, Pitt J, Handelsman E, Brambilla D, Moye J, Hoff R. Diagnosis of infection with human immunodeficiency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants' Transmission Study. J Pediatr. 1996 Aug; 129(2):198-207. PMID: 8765616

Mirochnick M, Cooper ER, McIntosh K. Pharmacokinetics of weekly and daily dapsone in HIV-infected children: ACTG Protocol 179. Society for Pediatric Research, Washington, DC. 1996.

Moye J, Rich KC, Kalish LA, Sheon AR, Diaz C, Cooper ER, Pitt J, Handelsman E. Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group. J Pediatr. 1996 Jan; 128(1):58-69. PMID: 8551422

Diaz C, Hanson C, Cooper ER, et al. Disease progression in a Cohort of HIV infected infants followed since birth: The Women and Infants Transmission Study (WITS). XI International Conference on AIDS, Vancouver, Canada. 1996.
Kovacs A, Bricker T, Bye M, Demmler G, Easley K, Cooper ER, et al. Rapid progression of HIV disease and increased CNS disease in infants with early CMV infection and altered immunity. Presented at the Eleventh International Conference on AIDS, Vancouver, Canada. 1996.

Chantry CJ, Cooper ER, Pelton SI, Zorilla C, Hillyer GV, Diaz C. Seroreversion in human immunodeficiency virus-exposed but uninfected infants. Pediatr Infect Dis J. 1995 May; 14(5):382-7.View Related Profiles.

Cooper, Ellen
Pelton, Stephen

PMID: 7638014

Lan Y, Japour AJ, Kim S, Welles SL, Crumpacker CS, Cooper E, Al-Attar I, McIntosh K. A rapid, direct test for zidovudine susceptibility in clinical isolates of human immunodeficiency virus type 1 (HIV-1) from infected children. Clin Diagn Virol. 1995 Mar; 3(3):259-71. PMID: 15566807

Cooper ER. Early testing for HIV can make all the difference. Kids: Our Common Wealth. 1995; 5(4):7.
Regan AM, Schwartz T, Cooper ER, Pelton SI. Clinical Care Manual for HIV Infection (Libman, Witzburg, eds.). Overview of pediatric HIV infection. Little Brown and Co. Boston. 1995; 631-650.
Chantry C, Cooper ER, Pelton SI, et al. Seroreversion in HIV exposed but non-infected infants. Southern Society for Pediatric Research, New Orleans, LA. 1995.
Rich KC, Sheon A, Kalish L, Diaz C, Cooper ER, et al. Somatic growth in pediatric HIV infection: Women and Infants Transmission Study. 19th AIDS Clinical Trials Group (ACTG) Meeting, Washington, DC. 1995.
Hanson IC, Pitt J, Sherrieb K, Cooper ER, et al. Follow-up of single positive or indeterminate HIV cultures among infants in a multi-state perinatal study. 33rd Meeting of the Infectious Diseases Society of America (IDSA), San Francisco, CA. 1995.
Rich KC, Brambilla DJ, Cooper ER, et al. CD8 lymphocyte activation in HIV-infected newborn infants: Risk for early positive HIV cultures and depressed CD4 + lymphocytes. 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Orlando, FL. 1994.
Cooper ER. HIV clinical trials: not for men only. In the Best Interests of the Children (ITBIC). 1994.

Barnett ED, Pelton SI, Mirochnick M, Cooper ER. Dapsone for prevention of Pneumocystis pneumonia in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J. 1994 Jan; 13(1):72-4.View Related Profiles.

Barnett, Elizabeth
Cooper, Ellen
Mirochnick, Mark
Pelton, Stephen

PMID: 8170736

Diaz C, Yogev R, Rogers A, Van Dyke R, Cooper ER, et al. A multicenter, phase I, dose escalating study of interferon-alpha alone and in combination with zidovudine (ZDV) in children with early HIV disease progression. X International Conference on AIDS, Yokohama, Japan. 1994.

Mofenson LM, Bethel J, Moye J, Flyer P, Nugent R. Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. J Acquir Immune Defic Syndr. 1993 Oct; 6(10):1103-13. PMID: 8105072

Breña AE, Cooper ER, Cabral HJ, Pelton SI. Antibody response to measles and rubella vaccine by children with HIV infection. J Acquir Immune Defic Syndr. 1993 Oct; 6(10):1125-9.View Related Profiles.

Cooper, Ellen
Cabral, Howard
Pelton, Stephen

PMID: 8410669

Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center. Pediatr Infect Dis J. 1993 Jun; 12(6):513-22. PMID: 8393969

Pelton SI, Breña A, Potts B, Cabral HJ, Cooper ER. The natural history and relevance of antibody to principal neutralizing domain in pediatric HIV. Frontiers in HIV Pathogenesis, Keystone Symposium, Albuquerque, NM. 1993.
Rich KC, Sheon A, Diaz C, Cooper ER, et al. Natural history of somatic growth in pediatric HIV infection: preliminary data of the Women and Infants Transmission Study (WITS). 1st National Conference on Human Retroviruses and Related Infections, Washington, DC. 1993.
Brambilla DJ, Rich KC, Pitt J, Cooper ER, et al. Early differences in lymphocyte subsets between HIV+ and HIV- infants. IX International Conference on AIDS, Berlin, Germany. 1993.
Regan AM, Schwartz T, Cooper ER, Pelton SI. Clinical Care Manual for HIV Infection (Libman, Witzburg, eds.). Overview of pediatric HIV infection. Little Brown and Co. Boston. 1993; 484-501.

Mofenson LM, Moye J, Bethel J, Hirschhorn R, Jordan C, Nugent R. Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. JAMA. 1992 Jul 22-29; 268(4):483-8. PMID: 1352363

Cooper ER, Pelton SI, et al. Cytomegalovirus infection in children with perinatal HIV infection. Annual Keystone Symposium, "HIV: Pathogenesis and Treatment", Keystone, CO. 1992.
Tormey P, Taylor R, Schwartz T, Cooper ER, et al. Public health measures to control common childhood diseases: The need for re-evaluation in the era of HIV. American Public Health Association 120th Annual Meeting, Washington, DC. 1992.
Moye J, Mofenson L, Cooper ER and the NICHD IVIG Clinical Trial Study Group. Clinical and immunological effects of IVIG begun in HIV infected children with > 200 CD4+ cells/mm3. Presented at the International Congress on Drug Therapy in HIV Infection, Glasgow, Scotland. 1992.
Cooper ER, Pelton SI, Breña A. Response to measles and rubella vaccine in children with HIV infection. VIII International Conference on AIDS, Amsterdam, The Netherlands. 1992.
Potts B, Pelton SI, Craven D, Cooper ER, et al. HIV specific immunity in pregnant women and their infants. National Cooperative Vaccine Development Group for AIDS, Richmond, VA. 1992.
Mofenson L, Moye J, Cooper ER, and the NICHD IVIG Study Group. Serious infection and mortality in HIV infected children in a clinical trial of IVIG. the 32nd Annual ICAAC, Anaheim, CA. 1992.
Cooper ER, Langlois MP, Regan AM. Detection of antibody to varicella zoster virus (VZV): Comparison of a rapid latex agglutination method and ELISA technique. 32nd Annual Meeting of Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA. 1992.
Cooper ER. Topic in review: advances in pediatric AIDS. Pediatric Alert. 1992; 17(12):62-64.
Miller TL, Awnetwant E, Morris V, Cooper ER, et al. Improvement in nutritional status of HIV infected children by gastrostomy tube feedings. American Gastroenterological Association Meeting, San Francisco, CA. 1992.
Cooper ER, Pelton SI. Management of HIV Infection in Infants and Children (Yogev, Connor, eds.). Physicians and AIDS: Occupational risks and responsibilities. Mosby Yearbook Medical Publishers. 1992; 563-580.
Cooper ER, Schwartz T, Breña A, Regan AM, Pelton SI. Cytomegalovirus as a co-factor in transmission and progression of perinatal HIV infection. Pediatric AIDS and HIV Infection. 1992; 3(6):302-307.

Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. N Engl J Med. 1991 07 11; 325(2):73-80. PMID: 1675763; DOI: 10.1056/NEJM199107113250201;

Schwartz D, Schwartz T, Cooper E, Pullerits J. Anaesthesia and the child with HIV infection. Can J Anaesth. 1991 Jul; 38(5):626-33. PMID: 1934217; DOI: 10.1007/BF03008200;

Miller TL, Orav EJ, Martin SR, Cooper ER, McIntosh K, Winter HS. Malnutrition and carbohydrate malabsorption in children with vertically transmitted human immunodeficiency virus 1 infection. Gastroenterology. 1991 May; 100(5 Pt 1):1296-302. PMID: 2013374

Cooper ER. Intravenous immune globulin in symptomatic HIV-infected children - An update on pediatric AIDS. Pediatric Alert. 1991; 16(18).
Pelton SI, Cooper ER, et al. Cytomegalovirus infection in children with symptomatic HIV infection. VII International Conference on AIDS, Florence, Italy. 1991.

Weiblen BJ, Lee FK, Cooper ER, Landesman SH, McIntosh K, Harris JA, Nesheim S, Mendez H, Pelton SI, Nahmias AJ, et al. Early diagnosis of HIV infection in infants by detection of IgA HIV antibodies. Lancet. 1990 Apr 28; 335(8696):988-90.View Related Profiles.

Cooper, Ellen
Pelton, Stephen

PMID: 1970106

Miller TL, Martin SR, Cooper ER, et al. Gastrointestinal inflammation and carbohydrate intolerance in HIV-infected children. Society for Pediatric Research, New Orleans, LA. 1990.

Cooper ER. Caring for children with AIDS: new challenges for medicine and society. Pediatrician. 1990; 17(2):118-23. PMID: 2356162

Cooper ER, Fine S, et al. Absence of complications from RSV in children with HIV infection. VI International Conference on AIDS, San Francisco, CA. 1990.
Chase C, Coulter D, Cooper ER, Schwartz T. Neurodevelopmental findings in symptomatic and asymptomatic infants with perinatally acquired HIV infection and their controls. 5th National Pediatric AIDS Conference, Los Angeles, CA. 1989.
LeMay MD, Cooper ER, Patel DK, Pelton SI. Proceedings of the V International Conference on AIDS, Montreal, Canada. Efficacy and safety of ketoconazole in HIV infected infants with mucocutaneous candidiasis. 1989.
Coulter DL, McCarten K, Cooper ER. Cranial ultrasound: An early indicator of HIV encephalopathy. Child Neurology Society Meeting, San Antonio, TX. 1989.
Cooper ER, Schwartz T, LeMay M, Fine A, Pelton SI. V International Conference on AIDS, Montreal, Canada. Clinical spectrum of human immunodeficiency infection in children less than four months of age. 1989.

Cooper ER, Pelton SI, LeMay M. Acquired immunodeficiency syndrome: a new population of children at risk. Pediatr Clin North Am. 1988 Dec; 35(6):1365-87.View Related Profiles.

Cooper, Ellen
Pelton, Stephen

PMID: 3059304

Cooper ER. AIDS in children: An overview of the medical, epidemiological and public health problems. New Eng J of Public Policy. 1988; 4:121-131.
DiFranco MJ, McLane MF, Cooper ER. IV International Conference on AIDS, Stockholm, Sweden. Elevated neopterin associated with clinical illness in pediatric AIDS. 1988.
Cooper ER. The epidemiology of influenza in childhood. In influenza update: the role of antiviral agents in prophylaxis and treatment – proceedings of a symposium. J of Respiratory Diseases. 1987; S23-S26.

Cooper ER, Ellison RT, Smith GS, Blaser MJ, Reller LB, Paisley JW. Rifampin-resistant meningococcal disease in a contact patient given prophylactic rifampin. J Pediatr. 1986 Jan; 108(1):93-6. PMID: 3080574

Cooper ER, Roe M, Wheeler R, Todd J. 24th Annual ICAAC, Washington, DC. Comparative trial of antibiotic device and conventional blood culture in pediatric patients. 1984.
Cooper ER, Ellison RT, Smith GS, Blaser MJ, et al. 24th Annual ICAAC, Washington, DC. Rifampin-resistant meningococcal disease in a prophylaxed contact. 1984.
Wheeler RC, Kishigama JK, Cooper ER, Roe MH, Todd JK. 23rd Annual ICAAC, Las Vegas, NV. Comparison o antimicrobial removal device and conventional blood culture systems using large and small volumes of seeded blood. 1983.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 143 publications over 36 distinct years, with a maximum of 12 publications in 1992

Bar chart showing 143 publications over 36 distinct years, with a maximum of 12 publications in 1992

Year	Publications
1983	1
1984	2
1986	1
1987	1
1988	3
1989	4
1990	4
1991	5
1992	12
1993	7
1994	4
1995	7
1996	6
1997	8
1998	7
1999	10
2000	8
2001	6
2002	1
2003	1
2004	3
2005	3
2006	4
2007	2
2008	3
2009	6
2010	5
2011	3
2012	3
2013	1
2014	2
2015	1
2017	3
2018	1
2020	1
2021	4